IP Watch: Roche, Rubicon, NuGen, Alere, Merck, Gen-Probe, Intel, and Others Win US Patents | GenomeWeb

Roche has been awarded US Patent No. 8,071,338, "Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5'-to-3' nuclease activity."

Nicolas Newton is named as the inventor on the patent.

Provides methods and compositions for amplifying a target sequence by suppressing amplification of related sequences.

Roche has also been awarded US Patent No. 8,071,303, "Reagents and methods for detecting Neisseria gonorrhoeae."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.